Leading Pharmaceutical Companies Present Industry Roadmap to Combat Antimicrobial Resistance Comprehensive roadmap lays out key commitments the pharmaceutical companies pledge to deliver by 2020 to reduce antimicrobial resistance Represents major milestone following the Industry Declaration signed in January 2016 at the World Economic Forum by more than 100 companies and trade associations NEW YORK, N.Y.,...
Read moreThis blog was originally posted on OECD Insights Antibiotics have made modern medicine possible. Before the discovery of penicillin in 1928 and the recognition of its therapeutic potential, there were few tools doctors could use when patients came to them with common or minor infections from simple paper cuts. Today, complex medical interventions are made...
Read moreGeneva, 14 September 2016 – The biopharmaceutical industry believes the UN High Level Panel on Access to Medicines (HLP) lent an unprecedented opportunity to address critical issues affecting the ability of millions of people in receiving the medicines and vaccines they need. Many of the HLP recommendations ignore the most common issues that hamper access...
Read moreAs regulatory stakeholders from around the world meet at the 17th International Conference of Drug Regulatory Authorities (ICDRA) in Cape Town, South Africa from 27 November to 2 December 2016 (http://www.icdra.co.za/), an open #preICDRA2016 conference, titled “Patients Are Waiting: How Regulators Collectively Make a Difference” will be convened from the 27-28 November 2016 at the...
Read moreResearch-based pharmaceutical industry contributes to key global health discussions at 69th World Health Assembly New resolutions adopted by the World Health Assembly included rules on relations the World Health Organization can have with the private sector, amongst others; structures for R&D funding and coordination; access to medicines and integrated health services; global sector strategies on...
Read moreThis is just a teaser of the session that took place at 2016 GHF ‘Shaping a sound supply chain ecosystem’ gathered speakers from BMS, IFPW Walgreens Boots Alliance, ICRC and WHO. Moderated by Scrip’s Sukaina Virji. To find out more about the complexities of the pharmaceutical supply chain, to hear what experts think are the...
Read moreThe session that took place at 2016 GHF ‘Shaping a sound supply chain ecosystem’ gathered speakers from BMS, IFPW Walgreens Boots Alliance, ICRC and WHO. Moderated by Scrip’s Sukaina Virji. To find out more about the complexities of the pharmaceutical supply chain, to hear what experts think are the essential elements for robust health policies...
Read moreWHA 69, Item 16.2: Follow-up to the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination Delivered by Mario Ottiglio, Director, Public Affairs, Communications and Global Health Policy, IFPMA Thank you for the opportunity to contribute to this important discussion today. IFPMA represents leading research-based pharmaceutical companies as well as...
Read more